# Clinical trials recruiting in Malaysia: 366 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 366 trials recruiting or not yet recruiting with a site in Malaysia, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Malaysia: 366 rows for $18.30, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 9 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/malaysia

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 366
- Recruiting or not yet: 366
- Read on: November 19, 2026

## Trials

The 25 newest of 366, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07947290 | Effects of PosBion® Supplementation on Intestinal Barrier Function in Adults With Irritable Bowel Syndrome | My Myracle Sdn.Bhd | Not applicable | Not yet recruiting | Irritable Bowel Syndrome (IBS) | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947290) |
| November 17, 2026 | NCT07943897 | PROTECT-HER KIT to Improve HPV Self-Sampling Uptake Among Women in Selangor | Universiti Teknologi Mara | Not applicable | Not yet recruiting | Cervical Cancer Screening, Human Papillomavirus Infection | 106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07943897) |
| November 13, 2026 | NCT07936825 | Intravenous LIGNOcaine for the POstoperative Sore Throat | University of Malaya | Phase 4 | Not yet recruiting | Postoperative Sore Throat, Cough, Hoarseness, Postoperative Complications, Intravenous Lidocaine | 398 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07936825) |
| November 12, 2026 | NCT07930507 | A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in... | AstraZeneca | Phase 3 | Not yet recruiting | Hypercholesterolemia | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930507) |
| November 6, 2026 | NCT07922746 | A Randomized Controlled SaCo-VLM Trial | University of Malaya | Not applicable | Not yet recruiting | General Anaesthesia Using Supraglotic Airway | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922746) |
| November 6, 2026 | NCT07922252 | Micronutrient Supplementation and Chronotherapy in Children With ADHD | UCSI University | Not applicable | Recruiting | Attention Deficit Hyperactivity Disorder (ADHD) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922252) |
| November 4, 2026 | NCT07915687 | Synbiotic as an Adjuvant Therapy for Dyslipidaemia and Gut Health | Universiti Teknologi Mara | Phase 2 | Not yet recruiting | Dyslipidemia | 190 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915687) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 3, 2026 | NCT07912879 | Clinical Evaluation of Dual-Plane Technique PN-Based Treatment for Horizontal Neck Lines Using DNA Fragment Opmizing Technology... | PharmaResearch Co.,Ltd | Observational | Not yet recruiting | Skin Aging, Horizontal Neck Lines | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912879) |
| November 3, 2026 | NCT07912814 | Clinical Research on Deep-Plane Rejuran S Injection for Improvement in the Apperance of Periorbital Hollowing Using a Cannula Technique | PharmaResearch Co.,Ltd | Observational | Not yet recruiting | Periorbital Hollowing, Skin Aging | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912814) |
| November 2, 2026 | NCT07911020 | Psychological and Physiological Effects of Three-Minute Breathing Space Meditation in UPM Postgraduate Students | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Stress, Anxiety, Depression | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911020) |
| October 30, 2026 | NCT07907991 | The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Chronic Obstructive Pulmonary Disease | 1,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907991) |
| October 30, 2026 | NCT07907640 | Real-world Effectiveness and Safety of Savagen (Sacubitril/Valsartan) in Malaysian HFrEF Patients | Sunway University | Observational | Not yet recruiting | Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907640) |
| October 27, 2026 | NCT07898007 | Trial Comparing miLOOP Device Assisted Phacoemulsification vs Standard Surgery for Dense Cataracts: Effects on Endothelial Cell Loss... | Universiti Kebangsaan Malaysia Medical Centre | Not applicable | Recruiting | Cataract, Endothelial Cell Density, Cumulative Dispersive Energy | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898007) |
| October 22, 2026 | NCT07888426 | Tolerability and Safety of Nano-Tocotrienols | University of Malaya | Phase 2 | Not yet recruiting | Type 2 Diabetes Mellitus (DM) | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888426) |
| October 20, 2026 | NCT07883447 | Intravenous Fish Oil Emulsion in Critically Ill Patients With High Inflammatory Status. | Sponsor not shown (see the record) | Phase 2 | Recruiting | Critical Illness | 159 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883447) |
| October 16, 2026 | NCT07879144 | Digital Nudges to Improve Heart Health Actions After Community Screening in Malaysia (NADI-MyHeartRisk) | Cardiovascular Advancement and Research Excellence Institute | Not applicable | Not yet recruiting | Cardiovascular Diseases, Cardiovascular Risk Factor | 6,588 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879144) |
| October 16, 2026 | NCT07877948 | Comparative Study of Combination Treatment of Bionerv E+ Versus Vitamin B Complex in Treatment of Diabetic Polyneuropathy in Type 2... | BREGO Life Sciences | Not applicable | Recruiting | Diabetic Foot Ulcer (DFU), Diabetic Symmetrical Polyneuropathy | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877948) |
| October 6, 2026 | NCT07861100 | A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Cardiovascular Risk, Obesity | 8,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861100) |
| October 1, 2026 | NCT07851025 | Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced... | AstraZeneca | Phase 3 | Recruiting | Epithelial Ovarian Cancer | 950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851025) |
| September 25, 2026 | NCT07843238 | Evaluation of a New Virtual Care Pathway for Older Adults With Noncommunicable Diseases | National University of Malaysia | Not applicable | Recruiting | Hypertension (HTN), Diabetes, Dyslipidaemia | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07843238) |
| September 25, 2026 | NCT07840859 | Clinical Effectiveness of Oxygen-Releasing Oral Gel as an Adjunct to Scaling and Root Debridement in Patients With Severe Periodontal... | Universiti Sains Malaysia | Not applicable | Not yet recruiting | Periodontitis | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840859) |
| September 24, 2026 | NCT07839780 | S-PRG Filler for Preventing White Spot Lesions During Orthodontic Treatment | National University of Malaysia | Not applicable | Not yet recruiting | White Spot Lesion of Tooth, Orthodontic Treatment, Enamel Demineralization, Fluoride Varnishes | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839780) |
| September 24, 2026 | NCT07839442 | CHIPCAT and HFMD-PREP for HFMD Prevention in Childcare Centres in Kota Kinabalu | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Hand, Foot and Mouth Disease, Infection Control | 780 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839442) |
| September 21, 2026 | NCT07830732 | A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A | Novo Nordisk A/S | Phase 3 | Recruiting | Haemophilia A | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830732) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| University Malaya Medical Centre | Kuala Lumpur | 58 |
| Sarawak General Hospital | Kuching | 37 |
| Hospital Kuala Lumpur | Kuala Lumpur | 27 |
| Hospital Pulau Pinang | George Town | 22 |
| Hospital Ampang | Ampang | 17 |
| Sunway Medical Centre | Subang Jaya | 16 |
| Universiti Malaya Medical Centre | Kuala Lumpur | 16 |
| Hospital Tengku Ampuan Afzan | Kuantan | 15 |
| Hospital Umum Sarawak | Kuching | 14 |
| Hospital Universiti Sains Malaysia | Kota Bharu | 13 |
| Hospital Raja Perempuan Zainab II | Kelantan | 12 |
| Hospital Raja Permaisuri Bainun | Ipoh | 12 |
| Pantai Hospital Kuala Lumpur | Kuala Lumpur | 11 |
| Hospital Canselor Tuanku Muhriz UKM | Cheras | 11 |
| Universiti Sains Malaysia | Pulau Pinang | 10 |
| Hospital Pakar Universiti Sains Malaysia | Kota Bharu | 9 |
| Hospital Sultanah Bahiyah | Alor Star | 9 |
| University of Malaya Medical Centre | Kuala Lumpur | 8 |
| Queen Elizabeth Hospital | Kota Kinabalu | 8 |
| Hospital Queen Elizabeth | Kota Kinabalu | 7 |
| Hospital Sultan Idris Shah Serdang | Kajang | 7 |
| Hospital Sultanah Aminah | Johor Bahru | 7 |
| National Cancer Institute | Putrajaya | 6 |
| Hospital Miri | Miri | 6 |
| Hospital Sultan Ismail | Johor Bahru | 6 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 3 |
| Phase 1 | 8 |
| Phase 1/2 | 8 |
| Phase 2 | 33 |
| Phase 2/3 | 14 |
| Phase 3 | 120 |
| Phase 4 | 17 |
| Not applicable | 116 |
| Observational | 47 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus, Type 2 | 17 |
| Carcinoma, Non-Small-Cell Lung | 16 |
| Renal Insufficiency, Chronic | 13 |
| Heart Failure | 12 |
| Cardiovascular Diseases | 11 |
| Hypertension | 10 |
| Breast Neoplasms | 9 |
| Lung Neoplasms | 6 |
| Obesity | 6 |
| Pulmonary Disease, Chronic Obstructive | 6 |
| Colorectal Neoplasms | 6 |
| Diabetes Mellitus | 6 |
| Kidney Diseases | 6 |
| Dyslipidemias | 6 |
| Glomerulonephritis, IGA | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Coronary Artery Disease | 5 |
| Stroke | 5 |
| Crohn Disease | 5 |
| Prostatic Neoplasms | 4 |
| Ischemic Stroke | 4 |
| Anxiety Disorders | 4 |
| Depression | 4 |
| Inflammation | 4 |
| Kidney Failure, Chronic | 4 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 32 |
| National University of Malaysia | 31 |
| University of Malaya | 25 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 17 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 16 |
| Universiti Sains Malaysia | 15 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 12 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 11 |
| Universiti Putra Malaysia | 11 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 8 |
| Universiti Kebangsaan Malaysia Medical Centre | 6 |
| Universiti Teknologi Mara | 6 |
| Monash University Malaysia | 5 |
| Hospital Universiti Sains Malaysia | 4 |
| Sunway University | 4 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 4 |
| [BeOne Medicines](https://specstream.ai/data/clinical-trials/company/beone-medicines) | 4 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 4 |
| Universiti Tunku Abdul Rahman | 3 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 3 |
| National University Hospital, Singapore | 3 |
| [Genzyme, a Sanofi Company](https://specstream.ai/data/clinical-trials/company/genzyme-a-sanofi-company) | 3 |
| [Aesculap AG](https://specstream.ai/data/clinical-trials/company/aesculap-ag) | 2 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 2 |
| [Daiichi Sankyo](https://specstream.ai/data/clinical-trials/company/daiichi-sankyo) | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Mexican restaurants in the United States](https://specstream.ai/data/businesses/mexican-restaurants/united-states)
- [Lebanese restaurants in the United States](https://specstream.ai/data/businesses/lebanese-restaurants/united-states)
- [Inspection companies in the United States](https://specstream.ai/data/businesses/inspection-companies/united-states)
- [Health insurance offices in the United States](https://specstream.ai/data/businesses/health-insurance-offices/united-states)
- [Food and beverage consultants in the United States](https://specstream.ai/data/businesses/food-and-beverage-consultants/united-states)
- [Engineering firms in the United States](https://specstream.ai/data/businesses/engineering-firms/united-states)
